Variant report
Variant | esv3463590 |
---|---|
Chromosome Location | chr3:162213624-162235677 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373925044 | chr3:162217223-162217224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2318455 | chr3:162217232-162217233 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs560682360 | chr3:162217235-162217236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527507313 | chr3:162217241-162217242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs144601591 | chr3:162217269-162217270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561201097 | chr3:162217305-162217306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529966621 | chr3:162217327-162217328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577804702 | chr3:162217335-162217336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183052062 | chr3:162217338-162217339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528133395 | chr3:162217364-162217365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs187789154 | chr3:162217389-162217390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546468570 | chr3:162217395-162217396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552331460 | chr3:162217397-162217398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs537360501 | chr3:162224885-162224886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550553093 | chr3:162224911-162224912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553882530 | chr3:162224914-162224915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1478154 | chr3:162224936-162224937 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs114839527 | chr3:162224937-162224938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs553227762 | chr3:162224941-162224942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555853588 | chr3:162224990-162224991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573303454 | chr3:162224997-162224998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112688282 | chr3:162225024-162225025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554813012 | chr3:162225089-162225090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574774413 | chr3:162225090-162225091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543785202 | chr3:162225137-162225138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563271277 | chr3:162225141-162225142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs6441508 | chr3:162225155-162225156 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs560644984 | chr3:162225203-162225204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540080586 | chr3:162225218-162225219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs545797875 | chr3:162225243-162225244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs564083986 | chr3:162225251-162225252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs559153361 | chr3:162225276-162225277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs35564383 | chr3:162225291-162225292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369328617 | chr3:162225395-162225396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528189991 | chr3:162225431-162225432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372972930 | chr3:162225567-162225568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs186092580 | chr3:162225572-162225573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs116756215 | chr3:162225573-162225574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs79574671 | chr3:162225600-162225601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs550892282 | chr3:162225630-162225631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs567988063 | chr3:162225660-162225661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs73025308 | chr3:162225665-162225666 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs535488529 | chr3:162225674-162225675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs535686931 | chr3:162225695-162225696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs140712772 | chr3:162225754-162225755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs370831960 | chr3:162225758-162225759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs566810974 | chr3:162225806-162225807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554222867 | chr3:162225808-162225809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200403293 | chr3:162225809-162225810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs574168181 | chr3:162225835-162225836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:162217200-162217400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr3:162224800-162226000 | Enhancers | Muscle Satellite Cultured Cells | -- |
3 | chr3:162225000-162225800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr3:162225400-162225800 | Enhancers | HSMM | muscle |
5 | chr3:162232600-162233000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr3:162235200-162236000 | Enhancers | Dnd41 | blood |